Patient Stories
-
ROBIN M.
In the three years since entering remission, I have become extremely active in cancer patient advocacy.
-
STACEY G
Feel the love that surrounds you because it’s everywhere and it’s such a beautiful thing to get to connect with that. And, just know that we’re all rooting for you.
-
KIMBERLY B.
My mission as a young survivor is to use my platform to educate as many folks as possible, and to help overcome some of the misconceptions surrounding this very preventable cancer.
What’s New
Bristol-Myers Squibb’s Opdivo ® (nivolumab) + Low- Dose Yervoy ® (ipilimumab) is the First Immuno-Oncology Combination Approved for MSI-H/dMMR mCRC Patients Who Progressed Following Treatment with a Fluoropyrimidine, Oxaliplatin and Irinotecan